Trial Profile
The Physiologic Effects of Intranasal Oxytocin on Sarcopenic Obesity
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Oxytocin (Primary)
- Indications Obesity
- Focus Therapeutic Use
- Acronyms INOSO
- 25 Sep 2020 Status changed from active, no longer recruiting to completed.
- 26 Feb 2019 Planned End Date changed from 1 Sep 2019 to 1 Dec 2019.
- 26 Feb 2019 Status changed from recruiting to active, no longer recruiting.